Roger C. Ngan
30 Gascoigne Road
Hong Kong Special Administrative Region
Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Development and validation of ACTTOP: a prediction model for severe anticancer treatment toxicities in older patients with solid malignancy.
Journal: Age and ageing
Published: May 03, 2025
First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two 'long responder' case reports and review of the current literature.
Journal: The Journal of international medical research
Published: September 07, 2023
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis.
Journal: Nature communications
Published: July 24, 2023
Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
Journal: JAMA network open
Published: July 17, 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Journal: The Lancet. Oncology
Published: February 01, 2023
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 28, 2022
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.
Journal: Clinical and translational radiation oncology
Published: November 08, 2021
A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancer.
Journal: Scientific reports
Published: October 29, 2021
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 17, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Journal: Breast cancer research and treatment
Published: April 08, 2021
Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
Journal: JNCI cancer spectrum
Published: February 05, 2021
Clinical outcomes of patients with ductal carcinoma in situ in Hong Kong: 10-year territory-wide cancer registry study.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: December 05, 2020
Last Updated: 09/26/2026